Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
1
Funding Rounds
$39.2m
Money raised
Overview
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Imcyse has raised a total of $39.2m in funding over 1 rounds.
Key Insights:
- Imcyse Series B round, June 2019: $39.2m
Imcyse Series B round, June 2019
$39.2m
Industries
Imcyse is active in the following industries: